Top Nanomedicine Companies in Israel

Nanocarry is at the forefront of nanomedicine, developing innovative brain therapeutics that integrate biological methods with nanoparticles, facilitating the delivery of biologics across the Blood Brain Barrier. Their pioneering approach aims to create first-in-class treatments for neuro-oncology and CNS diseases.

NanoGhost is a biotech company that specializes in nanomedicine by developing a targeted drug delivery platform using Nano-Ghosts derived from mesenchymal stem cells. This innovative approach leverages the natural ability of these stem cells to home in on cancer and inflammation sites, enhancing the precision of therapeutic interventions.

NanoPass Technologies specializes in innovative intradermal delivery solutions, utilizing its FDA-cleared MicronJet™ microneedles, which are based on advanced MEMS technology. This approach aligns with the principles of nanomedicine by enhancing the delivery of vaccines and drugs through minimally invasive methods.

LipoMedix is focused on developing an innovative cancer therapy using liposome delivery, which enhances the effectiveness and safety of a patented prodrug of mitomycin-C. This approach aims to provide cancer patients with a more potent treatment that has fewer side effects compared to conventional therapies.

Stem Cell Medicine is focused on developing cell therapy products that target chronic diseases, particularly neurological conditions like multiple sclerosis and pain. Their innovative approaches include the use of adipose-derived mesenchymal cells and genetically modified muscle progenitor cells, which may have implications for advancements in nanomedicine.

Infinity Medical is focused on enhancing digital health startups, including those like Genoox, which gathers genetic data in a comprehensive database. Their Polaris platform utilizes advanced computing to optimize molecular drugs, which is relevant to the field of nanomedicine.

Nanomedic's Spincare system revolutionizes wound therapy through its innovative nanofibrous matrix that promotes personalized and efficient healing. By enhancing patient comfort and reducing pain, Spincare supports a quicker recovery, making it a significant advancement in the field of nanomedicine.

Intragel is developing an innovative intra-tumoral injectable drug delivery system, SRGel, which enhances the release and effectiveness of anti-cancer medications for treating solid tumors. With over 15 years of experience in clinical trials and a strong focus on safe and effective cancer therapies, the company addresses the critical need for localized treatment through its continuous smart therapy approach.

Medinol announced FDA approval for its EluNIR-PERL™ drug-eluting stent, which is designed for treating coronary artery disease. The company's commitment to innovative interventional cardiology products highlights its focus on advancing medical technology.

The company, Mirror Biologics International Biopharmaceutical Co., is developing innovative immunotherapy solutions, particularly through its Mirror Effect® technology platform that enhances the immune response to combat cancer. Their lead product, AlloStim®, is advancing in clinical development and aims to provide effective and affordable alternatives to traditional chemotherapy.